ASCO 2024: Artificial Intelligence and Deep Learning in Prostate Cancer Pathology

ASCO 2024, Prostate Cancer, Prostate Cancer Pathology, Artificial Intelligence and Deep Learning in Prostate Cancer Pathology, TMPRSS2:ERG fusion status.

Related Keywords

Chicago ,Illinois ,United States ,Canada ,Georgia ,American ,Liang Cheng ,Zachary Klaassen ,Williamb Schwartz ,Laboratory Medicine ,Twitter ,Lancet Commission On Prostate Cancer ,Department Of Pathology ,Brown University ,American Society Of Clinical Oncology ,Translational Research ,Georgia Cancer Center ,Warren Alpert Medical School ,Clinical Oncology ,Lancet Commission ,Prostate Cancer ,Gleason Scores ,Gleason Grade Groups ,New England Journal ,Vice Chair ,Anatomic Pathology ,Molecular Pathology ,Urologic Oncologist ,Associate Professor ,Annual Meeting ,